ÂÜÀòÂÒÂ×

Andreas Tsitsos is the Chief Corporate Development Officer at ELIQUENT Life Sciences. Prior to this role, Andreas was the VP of Finance & Operations at Exeevo and held various positions at Syneos Health (previously INC Research/inVentiv Health), including Director of Corporate Development and Associate Director of Corporate Strategy & Development. Andreas has extensive experience in strategic transactions such as mergers and acquisitions, divestitures, and joint ventures. With a background in finance and corporate development, Andreas has successfully led global cross-functional teams through complex due diligence processes and negotiated transaction documents. Additionally, Andreas has a strong track record of creating value through strategic partnerships and business initiatives.